| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/12/2011 | EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY |
| 01/12/2011 | EP1317186B1 Improved bioactive whey protein hydrolysate |
| 01/12/2011 | EP1302541B1 Method for recognizing bacterial DNA |
| 01/12/2011 | EP1272206B1 A chicken II GnRH analog for use in reducing tumor cell growth |
| 01/12/2011 | EP1254951B1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method |
| 01/12/2011 | EP1163263B1 Dalda analogs and their use |
| 01/12/2011 | EP1109831B1 Cyctotoxic peptides modified by bulky or lipophilic moieties |
| 01/12/2011 | EP1105479B1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 01/12/2011 | EP1003782B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/12/2011 | EP0821736B1 Bacteriocins |
| 01/12/2011 | CN1982336B Human pancreas glucagon sample peptide-1-derivative, its production and use |
| 01/12/2011 | CN1943781B Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2011 | CN1933850B Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
| 01/12/2011 | CN1894273B Peptide inhibiting angiotensin converting enzyme |
| 01/12/2011 | CN1878565B Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins |
| 01/12/2011 | CN1856313B Therapeutic compounds |
| 01/12/2011 | CN1816566B VEGF traps and therapeutic uses thereof |
| 01/12/2011 | CN1777435B Method of purifying polypeptides by simulated moving bed chromatography |
| 01/12/2011 | CN101945888A Recovery of hydrophobic peptides from oils |
| 01/12/2011 | CN101945887A Cationic core-shell peptide nanoparticles |
| 01/12/2011 | CN101945665A Composition containing arazyme for the prevention and treatment of arthritis |
| 01/12/2011 | CN101945664A Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor |
| 01/12/2011 | CN101945648A Pharmaceutical formulation containing choline alfoscerate |
| 01/12/2011 | CN101942026A Long-acting interferon fusion protein and application thereof |
| 01/12/2011 | CN101942019A Factor VII or VIIa polypeptide variants |
| 01/12/2011 | CN101942018A Analogues of GLP-1 |
| 01/12/2011 | CN101942012A Polypeptide for preventing and treating angiogenesis and application thereof |
| 01/12/2011 | CN101942010A Method for promoting solid phase synthesis of balsam pear MC-JJ0106 polypeptide analogue by microwaves and application thereof |
| 01/12/2011 | CN101941977A Antitumoral analogs of lamellarins |
| 01/12/2011 | CN101940795A Applications of DLK1 gene, siRNA (small interference Ribonucleic Acid), BM-MSCs (Bone Marrow Mesenchymal Stem Cells) and FGF2 (Fibroblast Growth Factor2) |
| 01/12/2011 | CN101940785A Hydrogen sulfide-producing enzyme preparation and use thereof |
| 01/12/2011 | CN101940784A Novel ointment for treating microorganism infection skin disease and preparation process thereof |
| 01/12/2011 | CN101940783A Application of DNAzyme in preparing medicines for enhancing tumor chemotherapy sensitivity |
| 01/12/2011 | CN101940782A Lanreotide long-acting injection microsphere preparation and preparation method thereof |
| 01/12/2011 | CN101940781A New method for inhibiting synthesis of liver fat and preventing and treating fatty liver |
| 01/12/2011 | CN101940780A Zinc finger protein ZBTB20 in chondrocyte-specific knockout mouse model and application thereof |
| 01/12/2011 | CN101940589A Medicament for preventing and treating neurologic damage and related diseases thereof |
| 01/12/2011 | CN101940550A Preparation method of gonadotropin releasing hormone liposome |
| 01/12/2011 | CN101619316B Functional gene Rdr-onc sequence of rana chensinensis onconase sample, construction method, amino acid sequence thereof and application thereof |
| 01/12/2011 | CN101513395B Taxol double-layer soft capsule oral preparation medicament |
| 01/12/2011 | CN101433718B Biodegradable polypeptide vesicle loaded with hemoglobin and preparation method thereof |
| 01/12/2011 | CN101157729B Tumour putrescence gene related apoptosis ligand variant and uses thereof |
| 01/12/2011 | CN101148473B Recombination human insulin and its coding gene and application |
| 01/12/2011 | CN101029081B Recombinant incretin peptide and method for constructing and culturing producing strain |
| 01/11/2011 | US7868151 Recombinant human interferon-like proteins |
| 01/11/2011 | US7868138 mutant green fluorescent protein (GFP) with enhanced fluorescent intensity as compared to wild type Aequorea victoria GFP; use of repeated cycles of mutagenesis, in vivo recombination and selection which allow for the directed molecular evolution in vivo and in vitro of highly complex linear sequences |
| 01/11/2011 | US7868137 Search for cancer markers by a novel screening method |
| 01/11/2011 | US7868136 Search for cancer markers by a screening method |
| 01/11/2011 | US7868135 In particular amphomycin or aspartocin derivatives, and compositions of such lipopeptides for use in treating or preventing, for example, primary infection sites, secondary infections arising from a primary disease state, or infections associated with foreign bodies |
| 01/11/2011 | US7868133 For diagnosis, treatment, and prevention of apoptosis associated disorders using animal models; for drug screening; chimeras; genetic engineering, cancer |
| 01/11/2011 | US7867986 Enhanced drug delivery in transdermal systems |
| 01/11/2011 | US7867982 administering to a primate(human) an immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes to induce a CD8+T cell immune |
| 01/11/2011 | US7867978 Methods and compositions for treating neurological disorders |
| 01/11/2011 | US7867977 Immunogenic peptides and methods of use for treating and preventing cancer |
| 01/11/2011 | US7867976 Nogo epitopic fragments for modulating immune response |
| 01/11/2011 | US7867975 administering a nucleic acid comprising a coding region encoding endostatin; inhibiting angiogenesis in an angiogenesis-dependent site associated with macular degeneration; antiproliferative, anticarcinogenic and antitumor agents |
| 01/11/2011 | US7867974 orally administering to a patient a therapeutically effective amount of factor VIII in water to induce oral tolerance and supply exogenous factor VIII ( not present in liposome), for increasing hemostasis in the patient having hemophilia A; obtained from milk of a non-human transgenic mammal |
| 01/11/2011 | US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity |
| 01/11/2011 | US7867972 exendin-4 fused to a transferrin (Tf) via a polypeptide linker; for treatment of Type II diabetes, obesity, and to reduce body weight |
| 01/11/2011 | US7867747 for cerebral thrombosis and cerebral embolism; pulmonary embolism and pulmonary infarction; coronary artery necrosis, neuralgia, and hyperlipidemia; nephropathy; angina pectoris, ischemic heart disease, and myocardial infarction |
| 01/11/2011 | US7867743 phytases derived from Citrobacter braakii, belong to the acid histidine phosphatase family, are acid-stable, and expectedly of a high specific activity; animal feed |
| 01/11/2011 | US7867731 HX2004-6 polypeptide expressed in cancerous cells |
| 01/11/2011 | US7867729 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 01/11/2011 | US7867519 Method for the acceleration or deceleration of angiogenesis using fibrin matrix formed from increased or decreased HMW/LMW fibrinogen ratio |
| 01/11/2011 | US7867509 Fast dissolving orally consumable films |
| 01/11/2011 | US7867500 A carrier and a steroid receptor coactivator-1 and transcription intermediary factor-2 Associated Modulatory Protein (STAMP) that can modulate transcription of glucocorticoid-, progesterone-, mineralocorticoid- and androgen-responsive genes; conception (contraception), infertility, diabetes, cancer etc |
| 01/11/2011 | US7867498 comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides; for use in treatment and prevention of plasmodial infection; genetic vaccines; for immunization |
| 01/11/2011 | US7867496 Use of TGF-β antagonists to limit nephrotoxicity of immunosuppressive agents |
| 01/11/2011 | US7867492 Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies |
| 01/11/2011 | US7867489 Liquefying a vitreous and/or inducing posterior vitreous detachment of an eye via microplasmin injection; treating vision defects; preventing or reducing the risk of retinal detachment; catalytic domain of plasmin |
| 01/11/2011 | US7867488 Use of dendritic cells (DCs) expressing interleukin 12 (IL-12) |
| 01/11/2011 | US7867482 treating cancer responsive to interferon alpha therapy; the protein is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b) |
| 01/11/2011 | US7867481 Method of treating anemia by administering IL-1ra |
| 01/11/2011 | US7867480 Non-invasive vaccination through the skin |
| 01/11/2011 | CA2543009C Hydrochloride salts of a glycopeptide phosphonate derivative |
| 01/11/2011 | CA2471766C Compositions for improving lipid metabolism |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/11/2011 | CA2400486C Aniline-derived ligands for the thyroid receptor |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2349406C Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 01/11/2011 | CA2309541C Vegi, an inhibitor of angiogenesis and tumor growth |
| 01/11/2011 | CA2286313C Novel ldl-receptor |
| 01/11/2011 | CA2205092C Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 01/11/2011 | CA2156360C Adhesion receptor antagonists |
| 01/06/2011 | WO2011003100A2 Compositions and methods for diagnosing and/or treating influenza infection |
| 01/06/2011 | WO2011003098A1 Methods of stimulating liver regeneration |
| 01/06/2011 | WO2011003064A2 Methods of treating neuropathic pain |
| 01/06/2011 | WO2011003015A1 Nutritional supplement |
| 01/06/2011 | WO2011002834A2 Compositions and methods for diagnosis and treatment of type 1 diabetes |
| 01/06/2011 | WO2011002673A1 Leptin agonist and methods of use |
| 01/06/2011 | WO2011002332A1 Synthetic peptides having anti-stress activity |
| 01/06/2011 | WO2011002070A1 Pharmaceutical composition for treating iron overload disorders or diseases on which the reduction in iron concentration is effective, which comprises gdf7/bmp12 protein |
| 01/06/2011 | WO2011002066A1 Peptide and use thereof |
| 01/06/2011 | WO2011001897A1 Medicinal agent and method for treatment of intractable chronic hepatitis c |
| 01/06/2011 | WO2011001657A1 Polyionic dendrimer and hydrogel comprising same |
| 01/06/2011 | WO2011001366A1 N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease |
| 01/06/2011 | WO2011001097A1 Dermaseptin b2 used as an inhibitor of the growth of a tumor |
| 01/06/2011 | WO2011000929A1 Neurotoxins exhibiting shortened biological activity |
| 01/06/2011 | WO2011000924A1 Spray-dried amylase, pharmaceutical preparations comprising the same and use |
| 01/06/2011 | WO2011000523A1 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes |